Associations of hormones and menopausal status with depressed mood in women with no history of depression
- PMID: 16585466
- DOI: 10.1001/archpsyc.63.4.375
Associations of hormones and menopausal status with depressed mood in women with no history of depression
Abstract
Context: Whether depressed mood reported in the transition to menopause by women with no history of depression is associated with menopausal status and changes in reproductive hormones is controversial and lacks scientific information.
Objectives: To identify new onset of depressive symptoms and diagnosed depressive disorders in the menopausal transition and to determine the associations of menopausal status, reproductive hormones, and other risk factors with these cases.
Design: A within-woman, longitudinal (8-year) study to identify risk factors of depressed mood.
Setting: A subset of a randomly identified, population-based cohort.
Participants: Premenopausal women with no history of depression at cohort enrollment.
Main outcome measures: The Center for Epidemiological Studies of Depression scale (CES-D) was used to assess depressive symptoms, and the Primary Care Evaluation of Mental Disorders (PRIME-MD) was used to identify clinical diagnoses of depressive disorders.
Results: High CES-D scores (> or=16) were more than 4 times more likely to occur during a woman's menopausal transition compared with when she was premenopausal (odds ratio, 4.29; 95% confidence interval, 2.39-7.72; P<.001). Within-woman change in menopausal status, increased levels of follicle-stimulating hormone and luteinizing hormone, and increased variability of estradiol, follicle-stimulating hormone, and luteinizing hormone around the woman's own mean levels were each significantly associated with high CES-D scores after adjusting for smoking, body mass index, premenstrual syndrome, hot flashes, poor sleep, health status, employment, and marital status. A diagnosis of depressive disorder was 2(1/2) times more likely to occur in the menopausal transition compared with when the woman was premenopausal (odds ratio, 2.50; 95% confidence interval, 1.25-5.02; P=.01); the hormone measures were also significantly associated with this outcome.
Conclusion: Transition to menopause and its changing hormonal milieu are strongly associated with new onset of depressed mood among women with no history of depression.
Comment in
-
The menopausal transition increases the risk of depressive symptoms and depression diagnosis in women without a history of depression.Evid Based Ment Health. 2006 Nov;9(4):110. doi: 10.1136/ebmh.9.4.110. Evid Based Ment Health. 2006. PMID: 17065307 No abstract available.
Similar articles
-
Hormones and menopausal status as predictors of depression in women in transition to menopause.Arch Gen Psychiatry. 2004 Jan;61(1):62-70. doi: 10.1001/archpsyc.61.1.62. Arch Gen Psychiatry. 2004. PMID: 14706945
-
Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles.Arch Gen Psychiatry. 2006 Apr;63(4):385-90. doi: 10.1001/archpsyc.63.4.385. Arch Gen Psychiatry. 2006. PMID: 16585467
-
Associations of depression with the transition to menopause.Menopause. 2010 Jul;17(4):823-7. doi: 10.1097/gme.0b013e3181db9f8b. Menopause. 2010. PMID: 20531231 Review.
-
Symptoms associated with menopausal transition and reproductive hormones in midlife women.Obstet Gynecol. 2007 Aug;110(2 Pt 1):230-40. doi: 10.1097/01.AOG.0000270153.59102.40. Obstet Gynecol. 2007. PMID: 17666595
-
Depression during menopausal transition: a review of treatment strategies and pathophysiological correlates.Menopause Int. 2008 Sep;14(3):123-8. doi: 10.1258/mi.2008.008019. Menopause Int. 2008. PMID: 18714078 Review.
Cited by
-
Follicle-stimulating hormone induces depression-like phenotype by affecting synaptic function.Front Mol Neurosci. 2024 Oct 21;17:1459858. doi: 10.3389/fnmol.2024.1459858. eCollection 2024. Front Mol Neurosci. 2024. PMID: 39498265 Free PMC article.
-
Fitness consequences of depressive symptoms vary between generations: Evidence from a large cohort of women across the 20th century.PLoS One. 2024 Sep 30;19(9):e0310598. doi: 10.1371/journal.pone.0310598. eCollection 2024. PLoS One. 2024. PMID: 39348394 Free PMC article.
-
Endocrinological Treatment Targets for Depressive Disorder.Adv Exp Med Biol. 2024;1456:3-25. doi: 10.1007/978-981-97-4402-2_1. Adv Exp Med Biol. 2024. PMID: 39261421 Review.
-
Depressive symptoms over the final menstrual period: Study of Women's Health Across the Nation (SWAN).J Affect Disord. 2024 Dec 15;367:426-433. doi: 10.1016/j.jad.2024.08.237. Epub 2024 Sep 2. J Affect Disord. 2024. PMID: 39233250
-
Antidepressant- and Anxiolytic-like Effects of Pomegranate: Is It Acting by Common or Well-Known Mechanisms of Action?Plants (Basel). 2024 Aug 9;13(16):2205. doi: 10.3390/plants13162205. Plants (Basel). 2024. PMID: 39204642 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
